Skip to main content
. 2020 May 21;64(6):e02311-19. doi: 10.1128/AAC.02311-19

TABLE 1.

MIC of β-lactams against E. coli TOP10 isogenic strains producing various AmpC β-lactamases

AmpC β-lactamase MIC (μg/ml)a
CAZ CAZ-AVI AMX AMC PIP ETP MEM CF MA FOX CTX ATM FEP
Noneb 0.25 0.25 2 2 2 ≤0.06 ≤0.06 8 1 4 0.06 0.25 0.12
AmpCcloacae 64 0.25 >256 >256 128 0.25 ≤0.06 >256 256 128 64 32 1
AmpCcloacae N346Y 128 16 >256 >256 16 ≤0.06 ≤0.06 128 128 16 32 32 0.5
PDC-5 16 0.5 >256 >256 256 ≤0.06 ≤0.06 >256 256 128 32 16 0.5
PDC-5 N346Y 8 4 64 32 4 0.12 ≤0.06 128 16 128 4 1 0.25
DHA-1 256 0.25 >256 >256 256 ≤0.06 ≤0.06 256 128 16 16 16 0.12
DHA-1 N346Y 64 16 128 128 8 ≤0.06 ≤0.06 16 4 8 2 16 0.12
FOX-3 256 2 128 128 8 ≤0.06 ≤0.06 >256 256 256 16 8 0.5
FOX-3 I346Y 16 1 32 32 1 ≤0.06 ≤0.06 32 1 8 0.25 0.5 0.12
a

CAZ, ceftazidime; CAZ-AVI, ceftazidime combined with avibactam (4 μg/ml); AMX, amoxicillin; AMC, amoxicillin combined with clavulanate (2 μg/ml); PIP, piperacillin; ETP, ertapenem; MEM, meropenem; CF, cephalothin; MA, cefamandole; FOX, cefoxitin; CTX, cefotaxime; ATM, aztreonam; FEP, cefepime.

b

None, control pTRC-99k vector without any ampC-encoding gene.